India’s D2C ecosystem continues to witness strong momentum as homegrown brands scale globally and attract investor interest. In one of the latest developments in D2C news India, pet wellness brand Dogsee Chew is preparing to raise ₹300 crore to fuel manufacturing expansion, launch new products, strengthen working capital, and accelerate its next phase of growth across international markets.
The planned fundraise marks a significant milestone for the Bengaluru-based brand and highlights the growing confidence investors have in India’s emerging D2C pet care brands. Founded by Sneh Sharma and Bhupendra Khanal, Dogsee Chew has built a strong presence in the global pet wellness market through its natural and health-focused products. The company has already raised approximately ₹150 crore from investors including Sixth Sense, Mankind Pharma, and Ekta Group, and is now preparing for a larger funding round expected later this year.
As D2C startup news and D2C funding news continue to dominate conversations around India’s consumer internet landscape, Dogsee Chew stands out as one of the fastest-growing D2C brands India in the pet wellness category. The company currently operates in more than 30 countries and has established the United States as its largest market. Within just two years of entering the US, the market has grown to contribute nearly 70% of Dogsee Chew’s overall revenue, showcasing the strength of its global D2C business model India.
The upcoming ₹300 crore fundraise will play a critical role in supporting the brand’s ambitious D2C expansion plans. A significant portion of the capital will be invested in a new manufacturing facility, expanding production capacity, supporting product innovation, and strengthening marketing initiatives. The company currently operates five manufacturing and processing units across India, including facilities in Karnataka and Uttarakhand. Its current manufacturing capacity of approximately 100,000 kilograms per month is already fully utilized, and the new facility is expected to double capacity to 200,000 kilograms per month.
For investors tracking D2C funding rounds, VC-backed D2C brands, angel investment D2C opportunities, and top funded D2C brands, Dogsee Chew represents an example of how niche categories can evolve into globally competitive businesses. The company is targeting revenue of ₹250 crore this fiscal year and has recently achieved PAT profitability, further strengthening its growth story and demonstrating strong operating fundamentals.
While Dogsee Chew initially built its reputation through natural dog chews, the company has steadily evolved into a broader pet health and wellness platform. Today, its portfolio includes around 70 SKUs spanning functional treats, supplements, hip and joint care solutions, skin and coat products, allergy support, multivitamins, and other wellness-focused offerings. The company is also exploring newer categories such as omega oils and specialized health supplements, reflecting a clear D2C product launches strategy aimed at increasing customer lifetime value and category leadership.
The growth also aligns with larger D2C market trends 2025, where consumers are increasingly prioritizing premium, functional, and health-focused products. As pet ownership rises globally and pet parents spend more on wellness solutions, the opportunity for D2C pet care brands continues to expand rapidly.
Although international markets remain the primary growth engine, Dogsee Chew is now building a stronger India-focused strategy. The company plans targeted launches for Indian pet parents, including smaller SKUs, wellness supplements, and products designed for first-time pet owners. This approach reflects evolving D2C consumer behavior India and the growing adoption of premium pet care products in the domestic market.
For those following Indian D2C updates, D2C business India, D2C revenue growth, and India’s D2C market news and insights, Dogsee Chew’s planned ₹300 crore fundraise signals another strong chapter in the rise of globally scalable Indian consumer brands. With profitability achieved, manufacturing expansion underway, and international demand accelerating, the company is positioning itself as one of the most promising names in the global pet wellness industry.
